FDA Approves Remicade for Children with Crohn’s Disease
The Food and Drug Administration has approved Remicade (infliximab) to treat children with active Crohn's disease, a chronic, inflammatory condition of the bowel that can be severely debilitating.
del.icio.us
Digg this
